Puma Biotechnology | PBYI - Уставный капитал обыкновенных акций





Уставный капитал обыкновенных акций Изменить Дата
Agios Pharmaceuticals USD 59.6M 264K 2026-06
Alnylam Pharmaceuticals USD 133.88M 141K 2026-09
Amgen USD 541M 0 2026-09
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 193.54M 267K 2026-06
Daiichi Sankyo JPY 1.82B 1.68M 2026-09
Exelixis USD 244.68M 4.21M 2026-09
Gilead Sciences USD 1.24B 1000K 2026-06
Glaxosmithkline GBP 2.02B 2.03B 2026-09
Incyte USD 200.98M 1.03M 2026-06
MacroGenics USD 63.65M 86K 2026-06
Moderna USD 391M 2M 2025-09
Novartis USD 1.89B 12.09M 2026-09
Pfizer USD 5.7B 0 2026-06
PTC Therapeutics USD 83.33M 445K 2026-06
Puma Biotechnology USD 5K 0 2024-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
Sarepta Therapeutics USD 107.23M 1.61M 2026-09
Takeda JPY 1.58B 460K 2026-06
TG Therapeutics USD 153.08M 2.23M 2026-06
Ultragenyx Pharmaceutical USD 98.6M 300K 2026-06
Vanda Pharmaceuticals USD 58K 0 2024-12
Vertex Pharmaceuticals USD 253.5M 200K 2026-09